270 related articles for article (PubMed ID: 3291233)
21. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
[No Abstract] [Full Text] [Related]
22. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
Carpenter CB; Milford EL; Kirkman RL; Strom TB; Lazarus JM; Tilney NL
Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine immunosuppression for more than three years in kidney transplants.
Yagisawa T; Takahashi K; Toma H; Teraoka S; Fuchinoue S; Honda H; Agishi T; Ota K
Transplant Proc; 1988 Jun; 20(3 Suppl 3):92-8. PubMed ID: 3291325
[No Abstract] [Full Text] [Related]
24. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
[No Abstract] [Full Text] [Related]
25. Conversion of immunosuppression in renal allograft recipients from cyclosporine A to azathioprine and prednisolone 6 months after transplantation.
Lennard TW; Venning M; Donnelly PK; Wilson RG; Parrott NR; Elliott RW; Proud G; Farndon JR; Ward MK; Wilkinson R
Transplant Proc; 1987 Oct; 19(5):3594-6. PubMed ID: 3313866
[No Abstract] [Full Text] [Related]
26. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
[No Abstract] [Full Text] [Related]
27. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
28. Conversion from cyclosporine to azathioprine following heart transplantation.
McGiffin DC; Kirklin JK; McVay RF; Logic JR; Edwards ME; Diethelm AG
J Heart Transplant; 1986; 5(2):99-104. PubMed ID: 3302165
[TBL] [Abstract][Full Text] [Related]
29. Results of conversion immunosuppression in 193 cadaver and 42 living-related donor renal allografts.
Jacobson JE; Pontin A; van Zyl-Smit R; Pascoe M; Cassidy MJ; Swanepoel CR
Transplant Proc; 1988 Jun; 20(3 Suppl 3):155-6. PubMed ID: 3291232
[No Abstract] [Full Text] [Related]
30. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Stiller C; Keown P
Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
[No Abstract] [Full Text] [Related]
31. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
Hayes JM; Novick AC; Steinmuller DR; Streem SB; Hodge EE; Bretan PN; Cunningham R; Graneto D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):209-14. PubMed ID: 3291245
[No Abstract] [Full Text] [Related]
32. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
[No Abstract] [Full Text] [Related]
33. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
[No Abstract] [Full Text] [Related]
34. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation.
Kootte AM; Lensen LM; van Bockel JH; Paul LC
Transplant Proc; 1988 Jun; 20(3 Suppl 3):136-9. PubMed ID: 3291227
[No Abstract] [Full Text] [Related]
35. Ciclosporin in renal transplantation.
Land W; Castro LA; White DJ; Hillebrand G; Hammer C; Klare B; Fornara P
Prog Allergy; 1986; 38():293-328. PubMed ID: 3523493
[No Abstract] [Full Text] [Related]
36. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
37. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
[No Abstract] [Full Text] [Related]
38. Low-dose cyclosporine is safe in renal allografts with preexisting parenchymal damage.
Lustig S; Yussim A; Shaharabani E; Nakache R; Shmueli D; Bar-Nathan N; Boner G; Shapira Z
Transplant Proc; 1991 Feb; 23(1 Pt 2):1001-2. PubMed ID: 1989136
[No Abstract] [Full Text] [Related]
39. Conversion of cyclosporine to azathioprine in renal transplant patients.
Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
[No Abstract] [Full Text] [Related]
40. Management of cyclosporine toxicity by reduced dosage and azathioprine.
Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
